PTPA and breast neoplasm: While previous studies have reported breast tumor growth and poor outcomes associated with PP2A inhibitory protein overexpression and PP2A inactivation, Watt et al. demonstrated that loss of specific PP2A regulatory subunits is of likely functional significance in breast tumorigenesis [62].